Menu
Return To Home
ACR 2014
View Reports
Archive by Day
RheumReporters
All Meetings
About RheumReports
Contact Us
Past Coverage of ACR 2014
Past Coverage of ACR 2014
Return To RheumReports Home
ACR 2014
Archive
RheumReporter Bios
About RheumReports
Contact Us
Today's Featured
3 new reports
Loading
Connection Failure
RheumReports is made possible through the support of Janssen Inc.
NOVEMBER 25
Happiness From The Inside Out
2:49 AM ET
— via RheumReports
NOVEMBER 19
Featured
Over and Out from ACR 2014
10:14 PM ET
— via Dr. Andy Thompson
If Your RA Patient Says ‘My Joints Are Killing Me’ They May Be Correct
5:40 PM ET
— via Dr. Janet Pope
Is Calprotectin a Better Biomarker than ESR or CRP?
5:32 PM ET
— via Dr. Lillian Barra
Featured
If You Don't Treat to Target, the Patient Won't Get Better!
3:26 PM ET
— via Dr. Janet Pope
Musings from the ACR: Subsequent Entry Biologics
3:20 PM ET
— via RheumReports
Patients with Ankylosing Spondylitis are Less Reactive
2:06 PM ET
— via Dr. Andy Thompson
NSAID Use May Protect Against CV Risk in Ankylosing Spondylitis
2:04 PM ET
— via Dr. Sherry Rohekar
Featured
Cardiovascular Disease Risk Assessment - What You Should Do and Why
2:01 PM ET
— via Dr. Andy Thompson
Featured
Are Your Rheum Lexicon Matching Skills Up For the Test?
1:52 PM ET
— via Dr. Boulos Haraoui
Long-Term Outcomes Favourable for Rituximab Monotherapy in Cyroglobulinemic Vasculitis
1:38 PM ET
— via Dr. Lillian Barra
NOVEMBER 18
Bariatric Surgery Improves RA Outcomes
10:51 PM ET
— via Dr. Andy Thompson
Steroid Resistance - The Smoking Gun May Be a Smoking Mouse
10:01 PM ET
— via Dr. Janet Pope
Featured
More Evidence for Subcutaneous MTX - Why Are We Still Using Oral MTX?
9:05 PM ET
— via Dr. Andy Thompson
Lesinurad – A Novel Treatment for Gout?
8:54 PM ET
— via Dr. Andy Thompson
Fashion at the ACR: It's All About the Boots!
6:07 PM ET
— via Dr. Stephanie Keeling
Triple the Therapy, Triple the Savings?
6:03 PM ET
— via Dr. Stephanie Keeling
Cardiovascular Risks in Patients with RA
4:21 PM ET
— via Dr. Andy Thompson
Featured
Overview Day #4 (Wednesday, Nov 19) – Don't miss these sessions!
4:00 PM ET
— via Dr. Andy Thompson
RheumReports.com @Rheumreports
#ACR14 Franingham Risk does not perform well in seropositive RA.
http://t.co/p8jnlbKosx
2:00 PM ET
Current Event
RheumReports is made possible through the support of Janssen Inc.
Loading
All reports loaded
Connection Failure